Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,486 papers from all fields of science
Search
Sign In
Create Free Account
TNP 351
Known as:
TNP-351
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Methotrexate
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Novel pyrrolo[2,3-d]pyrimidine antifolate TNP-351: cytotoxic effect on methotrexate-resistant CCRF-CEM cells and inhibition of transformylases of de novo purine biosynthesis
F. Itoh
,
O. Russello
,
H. Akimoto
,
G. Beardsley
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 23870657
N-{4-[3-(2,4-Diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)propyl]benzoyl}-l-glutamic acid (TNP-351), characterized by a pyrrolo[2,3-d…
Expand
Highly Cited
2003
Highly Cited
2003
A new and efficient synthesis of pyrrolo[2,3-d]pyrimidine anticancer agents: Alimta (LY231514, MTA), homo-Alimta, TNP-351, and some aryl 5-substituted pyrrolo[2,3-d]pyrimidines.
E. Taylor
,
B. Liu
Journal of Organic Chemistry
2003
Corpus ID: 33926614
Alimta, as well as homo-Alimta, a nonbridged analogue of Alimta, and TNP-351 have been prepared by a new method that involves…
Expand
2000
2000
Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. III. Synthesis and biological properties of N(omega)-masked ornithine analogs.
F. Itoh
,
Y. Yoshioka
,
K. Yukishige
,
S. Yoshida
,
K. Ootsu
,
H. Akimoto
Chemical and pharmaceutical bulletin
2000
Corpus ID: 24883994
The glutamic acid moiety of N-[4-[3-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)propyl]benzoyl]-L-g lutamic acid (1b, TNP-351…
Expand
1997
1997
Growth inhibitory effects of antifolates against an adriamycin-resistant human small cell lung cancer cell line.
K. Matsuo
,
K. Kiura
,
+6 authors
M. Harada
Acta Medica Okayama
1997
Corpus ID: 20100382
We have established an Adriamycin (ADM)-resistant small cell lung cancer (SCLC) cell line, SBC-3/ADM 100, which shows…
Expand
1996
1996
Non-glutamate type pyrrolo[2,3-d]pyrimidine antifolates. II. Synthesis and antitumor activity of N5-substituted glutamine analogs.
F. Itoh
,
Y. Yoshioka
,
+4 authors
H. Akimoto
Chemical and pharmaceutical bulletin
1996
Corpus ID: 39959693
The glutamic acid moiety of N-[4-[3-(2,4-diamino-7H-pyrrolo[2, 3-d]pyrimidin-5-yl)propyl]benzoyl]-L-glutamic acid (1b, TNP-351…
Expand
1996
1996
A Ring-Transformation/Ring-Annulation Strategy for the Synthesis of the DHFR Inhibitor, TNP-351: A Correction.
E. Taylor
,
Zhenmin Mao
Journal of Organic Chemistry
1996
Corpus ID: 37213845
1995
1995
[The clinical phase I study of TNP-351. The TNP-351 Research Committee].
T. Taguchi
,
H. Niitani
,
+7 authors
T. Sasaki
Gan to kagaku ryoho. Cancer & chemotherapy
1995
Corpus ID: 42412894
The clinical phase I study of TNP-351, an antifolate drug having a novel structure, was performed through a multicenter…
Expand
1994
1994
Pharmacodynamics and factorial analysis of an anticancer agent, TNP-351.
T. Hishikawa
1994
Corpus ID: 75765067
1994
1994
Pharmacodynamics and factorial analysis of an anticancer agent, TNP-351.
菱川 保
,
白石 明
,
田口 鐵男
1994
Corpus ID: 90475006
Review
1992
Review
1992
[New analogues of methotrexate].
A. Yoshimura
Gan to kagaku ryoho. Cancer & chemotherapy
1992
Corpus ID: 33285406
New antifolate antimetabolites are currently developed and three analogues of methotrexate (MTX) (Trimetrexate, Edatrexate, TNP…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE